Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.

Objective: To assess the safety and effectiveness of eflornithine as first line treatment for human African trypanosomiasis.

Design: Cohort study.

Setting: Control programme in Ibba, southern Sudan.